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Changes in T cell trafficking accompany the naive to memory T cell antigen-driven dif-
ferentiation, which remains an incompletely defined developmental step. Upon priming, 
each naive T cell encounters essential signals – i.e., antigen, co-stimuli and cytokines – in 
a secondary lymphoid organ; nevertheless, its daughter effector and memory T cells 
recirculate and receive further signals during their migration through various lymphoid 
and non-lymphoid organs. These additional signals from tissue microenvironments have 
an impact on immune response features, including T cell effector function, expansion 
and contraction, memory differentiation, long-term maintenance, and recruitment upon 
antigenic rechallenge into local and/or systemic responses. The critical role of T cell 
trafficking in providing efficient T cell memory has long been a focus of interest. It is now 
well recognized that naive and memory T cells have different migratory pathways, and 
that memory T cells are heterogeneous with respect to their trafficking. We and others 
have observed that, long time after priming, memory T cells are preferentially found in 
certain niches such as the bone marrow (BM) or at the skin/mucosal site of pathogen 
entry, even in the absence of residual antigen. The different underlying mechanisms and 
peculiarities of resulting immunity are currently under study. In this review, we summarize 
key findings on BM and tissue-resident memory (TRM) T cells and revisit some issues 
in memory T cell maintenance within such niches. Moreover, we discuss BM seeding 
by memory T cells in the context of migration patterns and protective functions of either 
recirculating or TRM T cells.
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iNTRODUCTiON
When a pathogen attacks either skin or mucosa, primary immune responses are initiated in the 
draining lymph nodes (LN) and in some cases in the spleen. In these secondary lymphoid organs, 
mature antigen-presenting dendritic cells (DC) prime T cells to undergo huge clonal expansion 
and differentiation into short-lived effector and long-lived memory T cells. Both types of antigen-
experienced T cell migrate far from the original priming site, displaying increased capacity to 
migrate to inflamed tissues as well as to the bone marrow (BM) as compared with naive T cells. 
Activation-induced changes in T cell membrane expression of chemokine receptors, integrins, and 
other adhesion molecules underlie this homing behavior. At the end of effective responses, when 
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there is little or no residual antigen left, effector T cells die, leaving 
behind a small population of long-lived memory T cells, ready 
to provide protection in case of challenge with the same antigen. 
Memory T cells can be found all over the body, with a peculiar 
enrichment either in the BM or at the port of pathogen entry.
We will examine the evidence showing that memory T cells 
home to the BM and persist over time within this organ, being 
in constant exchange with blood T cell pool, whereas memory T 
cells residing at the port of pathogen entry (skin, etc.) are sessile. 
Moreover, we will review recent data and speculations on the 
niches wherein either BM or tissue-resident memory (TRM) T 
cells are maintained over time. We will discuss how BM memory 
T cells contribute to systemic memory, while TRM cells partici-
pate in local protection.
BONe MARROw MeMORY T CeLLS
A “Reservoir” of Memory T Cells in the BM
The BM consists of islets of hematopoietic BM interspersed with 
fatty areas, all contained within spongy bone and inside central 
cavities of long bones. It has long been known that in healthy 
individuals BM contains mature T cells, which can mediate graft-
versus-host disease in T-replete BM transplantation settings. T 
cells represent about 3–8% of total nucleated BM cells, and have a 
typically reduced CD4/CD8 T cell ratio, as compared with blood 
(1, 2). BM T cells include also regulatory CD4 T cells (3). No 
lymphatic drainage is present, thus BM exchanges with the rest 
of the body occur only through blood circulation.
Upon T cell priming induced via different routes, T cell con-
traction is less pronounced in the BM than in the spleen and other 
organs, and is followed by long-lasting persistence of BM antigen-
specific memory T cells (4–9). The BM also contains a high 
proportion of memory-phenotype T cells, i.e., a heterogeneous 
subset defined by the expression of activation/memory markers, 
which increases with aging and includes memory T cells specific 
for previously encountered antigens (10–12). BM memory T cells 
contain both central memory (TCM) and effector memory (TEM) 
T cells, two subsets of recirculating memory T cells identified in 
blood, having respectively high or low expression of the LN hom-
ing receptor CCR7 and distinct homing potential (13–16). Thus, 
the BM is often described as a “reservoir” for long-lived memory 
T cells (14, 15, 17).
Recirculating Memory T Cells in the BM
Pivotal experiments in sheep showed that T cells labeled in situ 
in the BM migrated out of the organ and reached the spleen 
and other secondary lymphoid organs (18), suggesting that the 
BM represents a temporary stopping point for recirculating 
memory T cells (2). In agreement with this notion, parabiosis 
experiments showed that about 2 weeks after surgery leading to 
anastomoses of blood vessels between two CD45-congenic mice, 
comparable numbers of CD45.1+ and CD45.2+ antigen-specific 
memory CD8 T cells were found in the BM of each parabiotic 
mouse (19). Furthermore, intra-vital dynamic imaging stud-
ies demonstrated that naive and memory CD8 T cells injected 
either into the carotid artery or intravenously entered the BM 
parenchyma of mouse skull and constantly crawled in it (14, 20). 
Competition among “rival” memory T cells for lodging into the 
BM was suggested by adoptive transfer experiments showing that 
memory-phenotype T cells entered BM more easily into young 
than in thymectomized old mice, where an existing memory T 
cell pool precluded their free access (11). Such competition with 
host T cells was lacking when BM T cell recipients were RAG1-
deficient mice (21). Thus, it appears that most BM T cells are 
motile recirculating cells. Some authors argued that the majority 
if not all of the BM memory T cells are non-migratory cells that 
permanently inhabit the BM; however, this speculation was based 
on cell phenotype, activation state, and gene expression analysis 
(22, 23) and did not take into account the in vivo data, including 
those obtained by in situ labeling, parabiosis, intra-vital dynamic 
imaging, and adoptive transfer (11, 14, 18–20). Nevertheless, 
the possibility that, similarly to thymus, LN, and spleen (24, 25), 
the BM also contains a few TRM cells cannot be excluded. For 
example, parabiosis experiments demonstrated that 3–5% of the 
antigen-specific memory T cells present in spleen and LN reside 
permanently in specific locations, i.e., the spleen marginal zone 
and red pulp and the LN sinuses (25).
In respect to the molecular players of memory T cell homing 
into the BM, memory CD8 T cells slow down and roll in BM 
microvessels via L-, P-, and E-selectin-mediated interactions (14). 
The BM tropism of memory T cells is supported by their high 
expression of the integrin VLA-4 (α4β1) and strong response to 
the BM chemokine CXCL12 (11, 14, 26). Conversely, only a few 
BM CD8 T cells express cutaneous lymphocyte antigen (CLA) 
and CCR9, involved in T cell homing to skin and gut, respectively 
(27). CD4 T cells lodge into the BM via molecular mechanisms 
at least partially similar to those of CD8 T cells. Expression of 
β1-integrin by CD4 T cells is required for their retention in 
the BM (28). In addition, CD4 T cell homing to BM is greatly 
reduced by anti-α2-integrin antibodies (21), suggesting a pivotal 
role for α2-integrin-mediated interactions, e.g., between the T 
cell integrin VLA-2 (α2β1) and type I collagen, which is highly 
abundant in bone. Both CD4 and CD8 T cell localization in the 
BM was compromised when mice lacked the adhesion molecule 
VCAM-1 (29).
Molecular regulation of T cell egress from the BM involves 
Sphingosine-1-phosphate (S1P) interaction with its receptor S1P1 
(30). S1P levels in the BM are lower than in plasma, so that CD4 
and CD8 T cells responding to S1P concentration gradient are 
normally recruited into the blood, unless S1P1 is pharmacologi-
cally inhibited by FTY720 (30). In agreement with the inhibition 
exerted by CD69 on S1P1 membrane expression and function 
(31), it was observed that CD69 ko memory CD4 T cells accu-
mulated in lower numbers in the BM as compared with their 
WT counterparts (32). However, CD69 deficiency did not cause 
CD4 T cell increase in blood, implying a more complex scenario 
(32). Since CD69+ cells but not CD69− cells were associated with 
laminin+ stromal cells in the BM, it was proposed that CD69 
could mediate retention of memory CD4 T cells within the BM 
(32). Taken together, these results suggest that CD69 regulates 
local T cell retention in the BM by a variety of mechanisms.
Certain infectious agents and cytokines can modulate BM T cell 
exchange with blood, for instance in Human Immunodeficiency 
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Virus (HIV)-infected individuals, CD4 T cells migrate to BM 
more rapidly than in healthy controls (33). Moreover, after 
Hematopoietic Stem Cell (HSC)-mobilization procedures, 
some T cell subsets and especially regulatory T cells increase 
in the blood, suggesting that they are mobilized from the BM 
(34, 35). Conversely, high levels of type I IFN induced by acute 
viral infections block T cell egress from lymphoid organs by a 
CD69-dependent mechanism (31). Further studies are required 
to define the rules governing changes in BM T cell recruitment 
into the blood upon peripheral and systemic immune responses 
(30, 36).
Antigen and Cytokines for BM Memory 
T Cells
Memory T cells specific for previously encountered antigens 
are commonly found in the BM of healthy subjects as well as 
of individuals affected by infectious, immune-mediated, and 
neoplastic diseases. For example, human BM from tetanus 
toxoid-vaccinated individuals contains tetanus-specific CD4 
T cells (22, 37), which can be transferred with BM grafts (37). 
Pathogen-specific CD4 and CD8 T cells were present not only in 
the BM of immune individuals after resolution of acute infections 
(22) but also in the BM of subjects infected by persistent viruses, 
including Cytomegalovirus (CMV), Epstein–Barr Virus (EBV), 
and Human Hepatitis C Virus (HCV) (16, 27, 38, 39). BM from 
neoplastic patients contained tumor antigen-specific T cells, 
even without intentional immunization (40, 41). Moreover, auto-
reactive T cells were found in the BM from individuals affected 
by autoimmune diseases (42).
In some of these cases, antigens were expressed in the BM, 
e.g., in EBV-infected subjects (27) or in idiopathic thrombocyto-
penia purpura patients (42). Though undetected, tumor antigen-
positive micro-metastatic cells could be present in patients with 
solid tumors (41, 43). However, the presence of antigen in the 
BM was not a reasonable possibility in other cases, for example 
long time after vaccination against tetanus (22, 37). In rodents, 
antigen-primed CD4 and CD8 T cell migration and retention into 
the BM were observed after peripheral immunization procedures 
that were unlikely to result in the presence of antigen in the BM 
(7, 44, 45). Hence, it appears that long-lived antigen-specific 
memory T cells lodge in the BM during immune responses to a 
variety of antigens, either localized in the BM or not (2).
Furthermore, mouse BM can be a major site of naive CD4 and 
CD8 T cell priming under conditions of disrupted lymphocyte 
trafficking in splenectomized mice (46). Blood-borne antigens 
can reach the BM and induce CD4 and CD8 T cell priming via 
BM-resident APC (20, 47). Moreover, circulating DC and even 
neutrophils can transport antigens to BM (48, 49). Altogether, 
these results show that, under certain circumstances, BM can 
function as a secondary lymphoid organ.
T cell contacts with other cells in BM niches and molecular 
interactions influencing T cell activation, proliferation, or sur-
vival in BM niches appear heterogeneous. Microscopy studies of 
BM sections documented that most mouse memory CD4 and 
CD8 T cells contacted IL-7+ VCAM-1+ stromal cells (21, 23, 50), 
whereas some were in proximity to either F4/80+ or CD11c+ cells 
(21, 51). Clusters of memory T cells and IL-15-producing cells 
were observed in human BM sections (52) while a population 
of 4-1BBL-expressing radioresistant stromal cells supporting 
memory CD8 T cell survival was described in mouse BM (51). 
In addition to 4-1BBL, other TNF family members have been 
involved in T cell survival within BM niches, e.g., GITRL (53–57).
Acquisition of a BM-Phenotype by 
Recirculating Memory T Cells
Elegant cellular barcoding experiments in mice clearly dem-
onstrated that after pathogen infection via a systemic route, 
pathogen-specific CD8 T cells from the BM and those from 
blood, spleen, and LN all derive from the same set of precursors 
(58). BM memory T cells exhibit some phenotypic differences 
when compared with corresponding cells from lymphoid periph-
ery and blood (7, 8, 22, 56, 59, 60). For example, a high propor-
tion of BM memory CD4 and CD8 T cells express CD69 (22, 
23, 32). Moreover, memory CD8 T cells from both mouse and 
human BM have a lower membrane expression of CD127, i.e., 
the IL-7Rα chain (8, 22, 59, 61), with the exception of antigen-
specific CD8 T cells from lymphocytic choriomeningitis virus 
(LCMV)-infected mice (23). The TNF-R family member GITR 
is selectively upregulated by a fraction of mouse BM memory 
CD8 T cells (56). Downregulation of CD127 and upregulation 
of GITR were both observed in BM but not in spleen samples 
from WT mice, while they were lost in IL-15 ko mice, suggesting 
that they are indirect evidence of IL-15 stimulation in BM (56, 
60). In agreement with these observations, adoptively transferred 
splenic CD8 T cells converted to BM-phenotype after entry into 
the BM (56, 60). Moreover, phospho-STAT-5 and phospho-p38 
MAPK were increased in freshly isolated BM CD8 T cells as 
compared with corresponding spleen cells, possibly reflecting 
molecular events in the BM, e.g., signaling by IL-15 and TNF 
family members (59).
No major differences were found by gene-expression analysis 
of memory T cell paired samples obtained from either BM or 
blood/spleen, for example mouse BM and spleen CD127+ mem-
ory CD8 T cells (23) and human BM and blood CD69− memory 
CD4 T cells (22). This may not be surprising, considering T cell 
recirculation and the shared ancestry between memory T cells 
present in BM and in other lymphoid organs (58). After in vitro 
stimulation, memory CD8 T cells freshly isolated from BM 
strikingly changed their transcriptional profile (23). Of note, BM 
and spleen memory CD8 T cells had a roughly similar global 
transcription profile following 2 days of in vitro stimulation with 
anti-CD3+ anti-CD28 beads (23), suggesting that the two types 
of cell shared a common set of genes poised to be expressed after 
activation (62, 63).
Taken together, these findings support the view that most BM 
memory T cells cannot be identified as a distinguished subset. 
They also suggest that BM memory T cells integrate various sig-
nals received in the organ, so that their activation state is different 
from that of recirculating memory T cells from other sources. 
However, after either egress from the BM or experimental isola-
tion, memory T cells only transiently retain some traits of the 
stimulation received in the organ (59).
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Contribution of BM T Cells to Memory 
Maintenance and Secondary Responses
Although the majority of BM memory T cells are quiescent, as 
demonstrated by staining with the cell cycle marker Ki67 (22, 23), 
a small percentage of them divides under steady state (8, 9, 60). 
Indeed, memory T cells have a higher rate of local proliferation 
in the BM than in spleen and LN, as demonstrated by a variety 
of experimental approaches (8, 9, 57, 59, 60, 64). For example, by 
Bromodeoxyuridine, carboxyfluorescein diacetate succinimidyl 
ester (CFSE), or DNA content assays, BM antigen-specific mem-
ory CD8 T cells contained a higher percentage of dividing cells 
than corresponding cells in spleen, LN, liver, and blood (8, 9). An 
increased proliferation in the BM was also observed in the case of 
naive CD8 T cells (59), although as expected their turnover was 
much lower than that of memory CD8 T cells (65). Estimates of 
T cell numbers strengthened the view that the BM gives a major 
contribution to long-term memory T cell maintenance, as well as 
to the homeostatic regulation of both memory and naive CD8 T 
cell numbers (2, 8, 9, 66, 67).
CD8 T cell proliferation in the BM is supported by local 
stimuli, including a dominant role for IL-15, as demonstrated 
by in vivo experiments with IL-15 ko and IL-15Rα ko mice (60). 
When tested in vitro, purified BM CD8 T cells did not exhibit an 
enhanced proliferative response to IL-7, IL-15, or IL-21 as com-
pared with spleen CD8 T cells (59). Adoptively transferred CD8 
T cells originally obtained from either BM or spleen similarly 
expanded in vivo after host injection with Poly I:C, a synthetic 
dsRNA analog inducing type I IFN and IL-15 (59), as well as upon 
secondary antigen challenge (68). Taken together, these data sup-
port the notion that BM T cells do not exhibit an intrinsic higher 
proliferative capability, but rather they are constantly stimulated 
in the BM (59).
Lack of memory T cell lodging into the BM can have a strong 
impact on memory T cell responses. For example, in CD69 
ko mice and in mice treated with anti-α2 integrin antibodies, 
CD4 T cells were greatly reduced in the BM and help for B cell 
response was defective (21, 32). Memory CD8 T cells lacking 
the transcription factor eomesodermin did not populate the BM 
niche and had impaired long-term persistence and secondary 
expansion (69). In contrast, β1 integrin-deficient CD4 T cells 
were not retained in the BM niche but proliferated normally in 
response to antigenic peptide plus LPS injection (28). Likewise, 
in the absence of CXCR4, anti-LCMV memory CD8 T cells were 
defective in migration into the BM, but displayed normal, or even 
greater, expansion upon secondary challenge with pathogen (70). 
Further studies are required to clarify these discrepancies, pos-
sibly due to pleiotropic effects of key molecule deficiency, and/
or differences in the measured aspect of memory response, e.g., 
T cell self-renewal in the memory phase, T cell expansion upon 
secondary response, or anti-pathogen protection, after different 
types of rechallenge.
BM Memory T Cells in Health and Disease
Bone marrow T cells exert potent antigen-specific effector func-
tion, as demonstrated by either adoptive transfers in immunode-
ficient mice (5) or in vitro studies (7). T cells from BM of patients 
with different types of solid and hematological cancers were able 
to kill autologous tumor cells (40, 71, 72). Adoptive transfer 
of BM T cells from breast cancer patients in immunodeficient 
mice induced regression of xenotransplanted autologous tumors, 
while blood T cells were not as effective (41). Clinical trials with 
autologous BM T cells have been initiated in various tumors 
(73), and the first trial in multiple myeloma patients looks very 
promising (74).
Moreover, it has been proposed that BM-based T cell prolif-
eration is one of the species-specific advantages allowing Simian 
Immunodeficiency Virus (SIV)-infected Sooty Mangabeys (SM) 
but not Rhesus Macaques (RM) to maintain normal CD4 T cell 
counts (75). Notably, SIV infection does not cause immunodefi-
ciency in SM, whereas it progresses to AIDS in RM, similarly to 
HIV infection in humans (75).
T cell-derived cytokines can modulate hematopoiesis, imply-
ing that BM T cells can contribute to shaping hematopoiesis 
during both acute and chronic infections (76). For example, 
IFN-γ released by T cells can either induce IL-6 production by 
BM stromal cells, in turn augmenting myelopoiesis (77), or also 
act directly on HSC (78–80).
Bone marrow can play a detrimental role in some T-cell 
mediated diseases by maintaining pathogenic T cells. In mouse 
models, pathogenic autoreactive T cells were found in the BM in 
organ-specific autoimmune diseases, e.g., type I diabetes (81) and 
chronic uveitis (82). Similarly, in mice with inflammatory colitis, 
pathogenic CD4 T cells were found in the BM (83). Interestingly, 
maintenance of pathogenic CD4 T cells required IL-7 in the 
BM, but not in the colon (84). Thus, it was proposed that, in the 
disease remission phase, colitogenic CD4 T cells persisted in the 
BM (83, 84).
Moreover, T cell effector function in the BM can stimulate 
pathological bone resorption, by activating osteoclasts. It is well 
established that CD4 T cells recruited in joints and periodontal 
tissue of patients affected by rheumatoid arthritis and periodonti-
tis, respectively, stimulate osteoclastogenesis by producing IL-17 
and RANK-L (85–88). Recently, a subset of osteoclastogenic 
Th17 TNF-α producing cells has been identified in PBMC from 
patients with Crohn’s disease, and it has been proposed that these 
cells can migrate to the BM and mediate bone loss, in agreement 
with mouse models (89–91). Notably, in a mouse model of breast 
cancer, pro-osteoclastogenic BM T cells favored the establish-
ment of skeletal metastases by inducing osteolytic lesions (92).
Finally, T cells regulate physiological processes occurring in 
the BM, i.e., normal hematopoiesis and bone tissue homeostasis. 
Surprisingly, the maintenance of normal bone mass and bone 
mineral density in physiological conditions is promoted by T cells, 
which stimulate the production of the RANK-L decoy receptor 
osteoprotegerin by B cells, through CD40L/CD40 interaction 
(93). A cross-talk between T cells and hematopoietic precursors 
occurs in the BM in normal healthy conditions (94, 95). For 
example, it has been shown that BM T cells sustain normal granu-
lopoiesis (94), while regulatory T cells inhibit excessive T cell-
production of the granulopoiesis-promoting cytokines GM-CSF, 
TNF, and IL-6, thus allowing for sufficient B lymphopoiesis (95). 
Regulatory T cells in the BM are required for HSC engraftment 
upon transplantation (96, 97), and likewise might protect normal 
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HSC and their niches from destructive immune responses (97). 
Taken together, these results suggest that BM T cells are engaged 
in a complex interplay with other cells in the local environment, 
contributing to maintain bone and BM integrity and function.
TiSSUe-ReSiDeNT MeMORY T CeLLS
A “Reservoir” of Memory T Cells in  
Non-Lymphoid Tissues
In addition to the BM and secondary lymphoid organs, the body’s 
surfaces such as the linings of the skin, gut, and reproductive tract 
also harbor large numbers of CD4 and CD8 T cells (6, 98–100). 
Most of these peripheral T cells are antigen-experienced memory 
cells and are generally believed to provide specific immunity against 
renewed infection with previously encountered pathogens. Given 
their location in close proximity to the external environment, it 
appears likely that some of these memory T cells also recognize 
commensal microbiota, and such T cell–microbiota interactions 
have been proposed to fine-tune peripheral immunity (101, 102).
While it is clear that T cells recirculate between peripheral 
tissues and the blood via the lymphatic system (103–105), 
there is recent evidence for a non-recirculating population of 
memory T cells that remain localized to peripheral tissues and 
never return to the blood (106, 107). Such TRM cells are best 
characterized for the CD8 subset and have been described in a 
large number of peripheral organs, including skin, gut, brain, 
salivary glands, lungs, female reproductive tract, and others (106, 
107). Furthermore, non-recirculating memory T cells also exist in 
lymphoid organs such as LN and thymus (24, 25).
Sessile TRM Cells Permanently Residing 
in Tissues
Various experimental strategies, such as organ transplantation, 
sex-mismatched adoptive T cell transfer, and parabiosis in mice 
have unequivocally demonstrated that TRM cells can persist in 
peripheral tissues in disconnection from the pool of recirculating 
T cells in the blood (108–111). In line with this, CD8 TRM cells 
are often found in specialized microanatomical compartments 
such as the epithelial layers of skin and gut where they are seques-
tered from direct lymphatic drainage by the underlying epithelial 
basement membrane.
These epithelial CD8 TRM cells commonly express surface 
receptors such as CD103 (the αE integrin subunit), CD69, and 
the integrin VLA-1 (α1β1), which are variously involved in T 
cell retention and persistence (107, 112). For instance, genetic 
deficiency in CD103 expression results in defective generation of 
CD8 TRM cells in gut mucosa (113, 114), abolished accumula-
tion of CD8 T cells in islet grafts (115), as well as a gradual loss 
of TRM cells from skin and lung mucosa (116, 117). Similarly, 
genetic or functional ablation of VLA-1 causes a dramatic decline 
in memory CD8 T cell numbers in lung after pulmonary virus 
infection (118). While these adhesion molecules are likely to 
mediate the tethering of TRM cells to their microenvironment, 
integrin binding and ligation may also support T cell survival and 
functional activity (119, 120). By contrast, the surface molecule 
CD69 can act to block the functional activity of the tissue exit 
receptor, S1P1, and thereby inhibit tissue egress of effector T cells 
with the potential to undergo local differentiation into TRM 
cells (31, 121). In addition to this posttranslational regulation of 
S1P1 function, the progressive transcriptional downregulation 
of S1P1 expression appears to be a critical checkpoint in the 
TRM maturation pathway in a variety of tissues (117, 122). The 
high level surface expression of CD69 by fully developed TRM 
cells further echoes the absence of S1P1 expression, rather than 
recent T cell receptor activation, as both molecules physically 
interact with each other, resulting in mutual inhibition of surface 
 expression (123).
In addition to epithelial CD103+CD8+ TRM cells, pheno-
typically and anatomically distinct CD103− CD8+ TRM cells, 
including those that form clusters at sites of intestinal infection 
with Yersinia pseudotuberculosis, have also been described more 
recently (100, 124). Likewise, presumably non-recirculating or 
long-term retained memory T cells have been identified among 
CD4+ memory T cells in a variety of tissues, including skin, as 
well as lung, gut, and vaginal mucosa (125–129). Some of these 
also express markers initially described for CD8+ TRM cells, such 
as CD69 and CD103, although the role of these molecules in 
tissue persistence of CD4+ TRM cells remains largely unknown. 
It is therefore likely that TRM cells exist among both CD4+ and 
CD8+ memory T cells, and future studies will have to compare 
the molecular and functional relationship between those different 
types of TRM cells. Nevertheless, given that the molecular path-
ways underpinning the maturation and persistence of TRM cells 
have so far most extensively been studied for CD103+ CD8+ TRM 
cells, we will focus our attention on this subset for the remainder 
of this article.
Antigen and Cytokines for CD103+ CD8+ 
TRM Cells
The highest frequencies of CD8+CD103+ TRM cells are found 
in previously infected or inflamed tissue (108, 110, 130), where 
TRM cells develop from infiltrating effector T cells during lesion 
resolution (114, 117). Accordingly, peripheral infection can be 
regarded as the principle inducer of TRM cells in barrier organs 
such as skin and mucosa. In addition, systemic infections that 
generate a large pool of memory precursor T cells disseminating 
throughout the body can give rise to TRM populations in a variety 
of barrier tissues and internal organs (6, 111, 113, 131). Likewise, 
repeated immunization has been shown to progressively build up 
considerable numbers of TRM cells even in non-infected areas 
of skin (110).
Tissue-resident memory precursor cells are found within the 
KLRG1− effector population that also contains the precursors of 
circulating memory CD8 T cells (114, 117, 132). Of note, TRM 
precursor effector cells rapidly cease to migrate through periph-
eral tissues after pathogen clearance (111, 130), meaning that the 
pool of TRM cells is established early after infection and remains 
stable with minimal external input thereafter.
The generation of TRM cells in infected skin is regulated by a 
complex interplay of processes such as peripheral infiltration, tis-
sue exit, local positioning, and survival, which ultimately results 
in the maturation of a long-lived population of TRM cells in the 
A Steady State
B Localized Response
skin
blood
skin
blood
bone 
marrow ?
bone 
marrow ?
Migration
Homeostatic Proliferation
Tissue-Resident Memory T cell
Recirculating Memory T cell
Antigen-Loaded APC
Antigen-Induced Proliferation
FiGURe 1 | Contribution of bone marrow memory T cells and 
tissue-resident memory T cells to long-lasting immunity. (A) Under 
steady state, Bone Marrow (BM) memory T cells are in constant exchange 
with the recirculating memory T cell pool, while tissue resident memory T 
(TRM) cells are fixed within peripheral organs, e.g., skin, in a quiescent state. 
Although the majority of BM memory T cells are quiescent, a minor 
proportion of them self-renew within BM niches, mostly in response to 
cytokines, e.g., IL-15. This homeostatic proliferation counterbalances losses 
due to cell death and contributes to maintain constant numbers of 
recirculating memory T cells over time (8, 9). The putative possibility that a 
few TRM cells exist in the BM is depicted. (B) When infection is localized in 
peripheral organs, TRM cells represent a first line of defense that is reinforced 
by the arrival of recirculating memory T cells, acting as a second line of 
protection. Antigen presented by APC in the peripheral tissue leads to 
immediate antigen-specific expansion and effector response of the TRM and, 
with some delay, of the newly recruited memory T cells (163, 164).
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epidermal layer. Indeed, epithelial infiltration is critical for TRM 
formation, at least in skin, since effector T cells that are prevented 
from epidermal entry by pertussis toxin treatment fail to gener-
ate long-lived CD103+ memory cells (117). This compartment-
specific generation of T cell memory in skin likely reflects the 
anatomical restriction of essential differentiation and survival 
factors such as TGF-β and IL-15 that are expressed at high levels 
in the epithelial layer. Further supporting this assumption, CD8 
T cells fail to acquire a CD103+ TRM phenotype and are lost from 
skin over time in absence of TGF-β and IL-15 signaling (117).
In addition to these roles of TGF-β and IL-15 in TRM differen-
tiation and survival in skin, the same or other essential cytokines 
and local factors may be involved in the establishment of TRM 
populations in an organ- or location-specific manner (113, 114, 
116). Local antigen recognition for instance is strictly required 
for the establishment of long-lived TRM populations in organs 
such as brain, sensory ganglia, and lungs (120, 130, 133, 134). By 
contrast, in many other peripheral tissues and internal organs, 
including skin, gut, kidneys, and salivary glands, local antigen 
recognition appears to be dispensable for TRM development (113, 
130). Nevertheless, it is conceivable that local antigen stimulation 
enhances TRM accumulation, possibly through the downregula-
tion of tissue exit receptors such as CCR7 or through direct effects 
on local proliferation and survival of TRM precursor cells.
Tissue-Specific Gene expression 
Signature of CD103+CD8+ TRM Cells
Importantly, local memory differentiation by tissue infiltrating 
effector T cells is accompanied by the progressive acquisition 
of a specific transcriptional program that distinguishes TRM 
cells from their TEM and TCM counterparts in the circulation 
(117, 122). Interestingly, the majority of these TRM-specific 
transcripts appear to be imprinted by the organ of residency. 
Skin CD8 TRM cells for instance express CCR8 whereas those in 
gut mucosa express CCR9 (130), and both chemokine receptors 
have been implicated in organ-specific homing to the respective 
anatomical locations. In addition, approximately a quarter of the 
TRM-specific transcripts are commonly up or downregulated in 
different CD103+ TRM cell populations from skin, gut, and lungs 
when compared to recirculating memory cells. This TRM-specific 
core transcriptional profile across a variety of organs comprises 
genes encoding for migration and adhesion molecules (e.g., Itga, 
Itga1, and S1pr1), transcription factors (e.g., Eomes, Hobit, and 
Litaf), immunoregulatory molecules (e.g., Cd244, Ctla-4, and 
Icos), and various enzymes (e.g., Inapp4b, Cmah, and Qpct) and 
likely echoes a common molecular program underpinning the 
formation, persistence, and function of CD103+ CD8 TRM cells 
in peripheral tissues (130).
Future work will have to define how stably this transcriptional 
profile is imprinted in TRM cells, and whether TRM cells can 
adopt alternative transcriptional and functional programs on 
renewed antigenic challenge or experimental release from the tis-
sue context. Relevant to this, it will be important to test whether 
the same epigenetic modifications that regulate chromatin 
accessibility and gene transcriptional programs in recirculating 
memory T cells (62, 63) also operate in TRM cells. Likewise, the 
extent to which the CD8 TRM transcriptional signatures and their 
putative epigenetic regulators overlap with those in CD103− and/
or CD4 TRM cells is currently unknown and needs to be tested. 
Regardless, there is accumulating evidence that a considerable 
proportion of T cells in peripheral non-lymphoid tissues adopt 
a phenotype and transcriptional profile that clearly distinguishes 
them from recirculating memory T cells.
Contribution of CD103+ CD8+ TRM Cells to 
Local immunity
Owing to their strategic location at body surfaces, TRM cells 
can immediately sense invading pathogens and initiate a rapid 
local immune response (112). In skin, for instance, TRM cells 
use dendritic protrusions to probe their environment, a behavior 
passing-through
Tissue-Resident
Migration
Homeostatic 
Proliferation
Recirculating
Memory T cells
Steady State
stopping-over
in blood
bone marrow
entryexit
?
FiGURe 2 | Stopping-over, passing-through and tissue-resident memory T cells in bone marrow. Under steady state, memory T cells migrate into the BM 
and then circulate back to the blood, with poorly defined kinetics. It is possible that some recirculating memory T cells quickly transit through the BM parenchyma 
while others stop over for some time within BM niches. A few memory T cells might stay permanently in BM niches and never return to the blood, representing the 
equivalent of tissue-resident memory (TRM) T cells identified in other organs.
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that reflects their active contribution to skin immune surveillance 
(109, 135). Following activation by their pathogen-specific T cell 
receptors, TRM cells produce a number of proinflammatory 
mediators, including the cytokines IFN-γ, TNF-α, and IL-2 (112, 
136–139). These mediators drive the local activation and recruit-
ment of innate and adaptive immune cells and also act on stromal 
and parenchymal cells to confer a resistance to pathogen dissemi-
nation (112, 136, 138, 139). In addition, TRM cell may directly 
lyse infected target cells, although the contribution of cytotoxicity 
in TRM-mediated protection remains to be demonstrated.
Tissue-resident memory cells have been shown to provide 
an exceptional level of immediate protection from renewed 
infection with a broad variety of viral and bacterial pathogens 
(108–110, 114, 134, 135, 138, 140). Furthermore, TRM cells 
generated by immunization strategies combining T cell priming 
with local treatment with inflammatory adjuvants provide a level 
of protection from de novo infection in skin and mucosa that is 
far superior to what can be achieved by circulating memory cells 
(130). Likewise, local immunizations with human papilloma 
virus vectors or treatment with T cell-attracting chemokines have 
been shown to generate protective TRM cells in vaginal mucosa 
and the female reproductive tract (141, 142).
Since these experiments confirm that TRM cells do not rely on 
antigen for long-term persistence, unlike other approaches used 
to generate T-cell immunity in peripheral tissues (143), TRM cells 
are now regarded as promising mediators of long-lived peripheral 
immunity for future vaccines (144). Importantly in this respect, 
a series of landmark papers have demonstrated the existence 
of Herpes Simplex Virus (HSV)-specific CD8+ memory T cells 
resident at the dermal-epidermal junction in human genital skin 
(145–147). Remarkably, these resident T cells share transcrip-
tional commonalities with HSV-specific TRM cells in mice (148) 
and are involved in preventing genital lesions upon asymptomatic 
HSV-2 shedding in skin (147). Furthermore, CD8+ memory T 
cells with a CD103+CD69+VLA-1+ TRM phenotype also exist in 
other human tissues (129, 149, 150). Such observations strongly 
argue that TRM cells are critical mediators of peripheral immu-
nity in both mice and humans, and it is has been speculated that 
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one of their principle functions is in dealing with recurrent or 
persistent infections in defined anatomical niches such as epithe-
lial or neuronal compartments (151).
While in such cases, TRM cells exert highly beneficial protec-
tive functions, pathogenic TRM responses may also cause tissue 
pathology. Supporting this notion, accumulation and aberrant 
activation of TRM cells have been described in localized and 
recurrent human diseases such as skin autoimmunity and 
transplant rejection (152). Early studies using xenotransplanta-
tion of pre-psoriatic human skin onto mice, for instance, have 
demonstrated that graft-derived human TRM cells, in absence of 
circulating memory T cells, are sufficient to drive development 
of psoriasis lesions through localized production of inflamma-
tory cytokines (153, 154). Similarly, IFN-γ producing epidermal 
TRM cells can initiate skin lesions upon ingestion of drugs that 
cause recurrent fixed drug eruptions (155), and CD8+ T cells 
with a TRM phenotype have been described in alopecia and 
vitiligo lesions (156, 157). Another impressive demonstration 
of TRM-mediated pathology in humans stems from a recent 
study that defined donor-derived TRM cells as the major drivers 
of localized rejection responses after face transplantation (158). 
Finally, CD103+CD8+ T cells make up a considerable propor-
tion of tumor-infiltrating lymphocytes in carcinomas and brain 
tumors, and their peri-tumoural accumulation is associated with 
improved clinical outcomes (159–162).
In summary, an accumulating body of literature implies a 
critical role of protective as well as pathogenic TRM responses in 
infectious and inflammatory diseases in humans. While so far this 
has most intensively been studied in easily accessible organs such 
as skin, it is tempting to speculate that TRM cells act as central 
mediators of localized diseases also in lungs, gut, and many other 
internal organs. Future studies will have to further clarify the role 
of protective and pathogenic TRM cell responses in humans and 
will have to explore avenues for their prophylactic or therapeutic 
manipulation in experimental and clinical settings.
CONCLUDiNG ReMARKS
The postulated division of labor between recirculating memory 
T cells and TRM cells offers a novel view of both memory main-
tenance and response to antigenic rechallenge that integrates 
and broadens the previous perspective based on TCM/TEM 
paradigm (13).
Long-lived persistence of memory T cells is achieved in the 
steady state by different mechanisms. Recirculating memory T 
cells rely on a finely tuned equilibrium between quiescence and 
homeostatic proliferation, which is mostly achieved within the 
BM niches wherein these cells temporarily stop. In contrast, 
TRM cells live permanently as sessile non-migratory cells within 
skin/mucosal niches, wherein they survive in a quiescent state 
(Figure 1A).
It appears that recirculating memory T cells and TRM cells 
provide respectively systemic immunity and immediate protec-
tion at the port of pathogen entry. Yet, the two types of memory T 
cells act in concert for tissue protection as recirculating memory 
T cells are recruited to skin or mucosal sites of secondary chal-
lenge, resulting in both more efficient local effector response 
and boosting of systemic memory (Figure  1B). Naturally, 
recirculating memory T cells arrive with some delay in the tissue, 
while TRM cells are already there for highly efficient immediate 
protection.
Taking into consideration that TRM cells have been identified 
not only at the epithelial barriers of the body but also in lymphoid 
and/or internal organs, e.g., LN and brain (106, 107), it is likely 
that each organ harbors some TRM cells and that BM is not an 
exception to this rule (Figure 1). The peculiarity of the BM would 
be that under steady state most memory T cells in it belong to the 
recirculating pool. Some heterogeneity might exist in the kinetics 
of recirculating memory T cell transit into the BM, with some 
cells just quickly passing through and others stopping over dur-
ing their journey, thus inhabiting for some time the BM niches 
wherein they receive signals for survival/homeostatic prolifera-
tion (Figure 2).
Despite their different migration pathways, positioning and 
role in immunity, both TRM and BM T cells participate in a local 
network of cellular and molecular interactions in the organ where 
they are located, influencing normal tissue homeostasis and organ 
function. In the case of BM T cells, it has been shown that they 
normally regulate hematopoiesis, as well as bone metabolism. In 
respect with TRM cells located in barrier organs, it is conceivable 
BOX 1 | Unsolved questions on bone marrow (BM) memory T cells 
and tissue-resident memory (TRM) T cells.
Tissue-specific signals for differentiation: After naive T cell priming, what 
are the distinct signals regulating differentiation of either recirculating memory 
T cells or TRM cells? Do recirculating memory T cells integrate signals for 
differentiation they receive over time in diverse environments (e.g., within 
BM, spleen, and LN)? Do TRM cells lodged in diverse tissues receive in each 
location a specific combination of signals for differentiation?
Tissue-specific signals for survival/homeostatic proliferation: What are 
the external signals regulating the long-lasting maintenance of recirculating 
memory T cells within BM niches and/or TRM cells within tissue niches? 
What is the role of external signals (including antigen, IL-15, TGF-β, etc.) in 
the quiescence/self-renewal of BM memory T cells and/or in the survival in a 
quiescent state of TRM cells?
Heterogeneity: If TRM cells receive a specific combination of signals for 
differentiation and maintenance in each organ or location, and if recirculating 
memory T cells integrate diverse signals over time, are TRM cells, taken as 
a whole, expected to be more heterogeneous than recirculating memory T 
cells? Is it conceivable that several different subsets of location-specific TRM 
cells do exist?
Intracellular networks orchestrating differentiation: What are the intracellu-
lar molecular pathways regulating differentiation and stable genetic imprinting 
or plasticity of TRM and recirculating memory T cells? How do key intracellular 
molecules regulate epigenetic marking, gene transcription, protein translation, 
metabolic state of TRM and of recirculating memory T cells?
Regulation of absolute cell numbers: Is homeostatic maintenance of 
memory T cell numbers independently regulated for TRM cells and for recircu-
lating memory T cells (including those in BM, spleen, and LN)?
CD4 and CD8 T cells: Do TRM cells resemble recirculating memory T cells 
in respect to the shared and/or specific protective functions of the CD4 and 
the CD8 T cell subsets? Are differentiation and maintenance of the CD4 TRM 
similar to those of the CD8 TRM?
Aging: Are there changes occurring with aging in the distribution of tasks 
between TRM and recirculating memory T cells?
Normal tissue homeostasis and organ function: Do BM memory T cells 
and TRM cells play a role in maintaining normal tissue homeostasis and organ 
function?
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